ArticleOncogene2022

Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment.

Klaire Yixin Fjæstad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.